Clinical Trials Logo

Clinical Trial Summary

In this study, we will evaluate the diagnostic yield of the new AliveCor device versus a 14 day event monitor with the use of both devices simultaneously. We will also examine by means of a questionnaire the compliance, ease of use and patient satisfaction for each device. Hypothesis: 1. The AliveCor monitor will be non-inferior to the 14 day event monitor with respect to diagnosis of the arrhythmia responsible for a patient's symptoms. 2. The AliveCor monitor will have better compliance and acceptability compared to the 14 day event monitor, and thus there will be a greater number of days with recordings from the AliveCor monitor.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02005172
Study type Interventional
Source University at Buffalo
Contact
Status Completed
Phase N/A
Start date November 2013
Completion date May 2016